These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 36327134)
21. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population. Proctor SL; Estroff TW; Empting LD; Shearer-Williams S; Hoffmann NG J Addict Med; 2013; 7(1):17-24. PubMed ID: 23131838 [TBL] [Abstract][Full Text] [Related]
22. Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis. Lake S; Walsh Z; Kerr T; Cooper ZD; Buxton J; Wood E; Ware MA; Milloy MJ PLoS Med; 2019 Nov; 16(11):e1002967. PubMed ID: 31743343 [TBL] [Abstract][Full Text] [Related]
23. Probability and correlates of transition from cannabis use to DSM-5 cannabis use disorder: Results from a large-scale nationally representative study. Feingold D; Livne O; Rehm J; Lev-Ran S Drug Alcohol Rev; 2020 Feb; 39(2):142-151. PubMed ID: 31916333 [TBL] [Abstract][Full Text] [Related]
24. Conceptualizing problematic use of medicinal Cannabis: Development and preliminary validation of a brief screening questionnaire. Feingold D; Gliksberg O; Brill S; Amit BH; Lev-Ran S; Kushnir T; Sznitman SR Addict Behav; 2024 Nov; 158():108122. PubMed ID: 39128420 [TBL] [Abstract][Full Text] [Related]
25. Risk and benefit of cannabis prescription for chronic non-cancer pain. Zloczower O; Brill S; Zeitak Y; Peles E J Addict Dis; 2022; 40(2):157-167. PubMed ID: 34338621 [TBL] [Abstract][Full Text] [Related]
26. Dual cannabis and alcohol use disorders in young adults: Problems magnified. Hayaki J; Anderson BJ; Stein MD Subst Abus; 2016; 37(4):579-583. PubMed ID: 27070725 [TBL] [Abstract][Full Text] [Related]
27. Problem alcohol use and healthcare utilization among persons with cannabis use disorder in the United States. John WS; Wu LT Drug Alcohol Depend; 2017 Sep; 178():477-484. PubMed ID: 28711814 [TBL] [Abstract][Full Text] [Related]
28. Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Lev-Ran S; Imtiaz S; Taylor BJ; Shield KD; Rehm J; Le Foll B Drug Alcohol Depend; 2012 Jun; 123(1-3):190-200. PubMed ID: 22143039 [TBL] [Abstract][Full Text] [Related]
29. Cannabis-based medicines for chronic neuropathic pain in adults. Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392 [TBL] [Abstract][Full Text] [Related]
30. Self-reported symptoms of cannabis use disorder: Psychometric testing and validation. Richards DK; Schwebel FJ; Sotelo M; Pearson MR; Exp Clin Psychopharmacol; 2021 Apr; 29(2):157-165. PubMed ID: 34043399 [TBL] [Abstract][Full Text] [Related]
31. An exploration of multivariate symptom clusters of cannabis use disorder in young adults. Howe LK; Bailey AJ; Ingram PF; Finn PR Addict Behav; 2022 Dec; 135():107465. PubMed ID: 35995015 [TBL] [Abstract][Full Text] [Related]
32. Predictors of treatment utilization and barriers to treatment utilization among individuals with lifetime cannabis use disorder in the United States. Kerridge BT; Mauro PM; Chou SP; Saha TD; Pickering RP; Fan AZ; Grant BF; Hasin DS Drug Alcohol Depend; 2017 Dec; 181():223-228. PubMed ID: 29107786 [TBL] [Abstract][Full Text] [Related]
33. Concomitant cannabis abuse/dependence in patients treated with opioids for non-cancer pain. Hefner K; Sofuoglu M; Rosenheck R Am J Addict; 2015 Sep; 24(6):538-45. PubMed ID: 26246069 [TBL] [Abstract][Full Text] [Related]
34. Factors associated with the timing and onset of cannabis use and cannabis use disorder: results from the 2007 Australian National Survey of Mental Health and Well-Being. Butterworth P; Slade T; Degenhardt L Drug Alcohol Rev; 2014 Sep; 33(5):555-64. PubMed ID: 25186194 [TBL] [Abstract][Full Text] [Related]
35. Cannabis Use and its Association with Psychological Disorders. Urits I; Gress K; Charipova K; Li N; Berger AA; Cornett EM; Hasoon J; Kassem H; Kaye AD; Viswanath O Psychopharmacol Bull; 2020 May; 50(2):56-67. PubMed ID: 32508368 [TBL] [Abstract][Full Text] [Related]
36. [Benefits and harms of cannabis-based medicines from the viewpoint of patients with chronic pain and their physicians : A cohort study in three pain centers of the German federal state Saarland]. Böttge-Wolpers C; Bialas P; Gottschling S; Juckenhöfel S; Konietzke D; Madlinger A; Welsch P; Häuser W Schmerz; 2024 Aug; 38(4):241-249. PubMed ID: 36662296 [TBL] [Abstract][Full Text] [Related]
37. Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only. De Aquino JP; Sofuoglu M; Stefanovics E; Rosenheck R Am J Drug Alcohol Abuse; 2019; 45(5):527-537. PubMed ID: 31112429 [No Abstract] [Full Text] [Related]
39. Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study. Quick CR; Conway KP; Swendsen J; Stapp EK; Cui L; Merikangas KR JAMA Psychiatry; 2022 Jul; 79(7):727-735. PubMed ID: 35648395 [TBL] [Abstract][Full Text] [Related]
40. Functioning of cannabis abuse and dependence criteria across two different countries: the United States and The Netherlands. Delforterie M; Creemers H; Agrawal A; Lynskey M; Jak S; van der Ende J; Verhulst F; Huizink A Subst Use Misuse; 2015 Jan; 50(2):242-50. PubMed ID: 25363693 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]